Amryt reports strong 2017 as revenues rise to almost €13m – Irish Times
Irish Times |
Amryt reports strong 2017 as revenues rise to almost €13m
Irish Times Biopharmaceutical firm Amryt said it had a strong year in 2017 as revenue rose to almost €13 million. The company, which focuses on rare and orphan diseases, also said it has signed a deal with UCD for a gene therapy platform that could offer a … Irish company focused on bad cholesterol treatment sees revenue increase to €13m |
